Lavipharm S.A. (ATH:LAVI)

Greece · Delayed Price · Currency is EUR

1.540

+0.008 (0.52%)

Apr 30, 2026, 5:10 PM EET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Production and Distribution of Pharmaceutical Products	62.58M	52.95M	-	-	-
Production and Distribution of Pharmaceutical Products Growth	18.20%	-	-	-	-
Medicines	-	-	47.44M	34.18M	34.28M
Medicines Growth	-	-	38.78%	-0.28%	8.01%
Services	-	-	400.00K	1.45M	1.43M
Services Growth	-	-	-72.32%	1.12%	-3.38%
Parapharmaceuticals	-	-	-	3.43M	4.02M
Parapharmaceuticals Growth	-	-	-	-14.59%	-9.18%
Total	62.58M	52.95M	47.84M	39.06M	39.72M
Total Growth	18.20%	10.68%	22.48%	-1.68%	5.54%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Greece	38.81M	28.44M	21.55M	31.18M	27.58M
Greece Growth	36.44%	32.02%	-30.91%	13.07%	6.69%
European Union	17.62M	18.83M	22.75M	12.20M	10.41M
European Union Growth	-6.42%	-17.22%	86.44%	17.16%	-8.39%
Other countries	6.15M	5.68M	3.55M	2.62M	1.73M
Other countries Growth	8.44%	59.99%	35.18%	51.41%	310.66%
Total	62.58M	52.95M	47.84M	46.01M	39.72M
Total Growth	18.20%	10.68%	3.98%	15.82%	5.54%

Source: S&P Global Market Intelligence.